Dr. Red­dy's, Tor­rent Phar­ma and Lau­rus Syn­the­sis all land Form 483 let­ters fol­low­ing FDA in­spec­tions

In De­cem­ber the FDA hit In­dia-based Tor­rent Phar­ma­ceu­ti­cals, Lau­rus Syn­the­sis and Dr. Red­dy’s Lab­o­ra­to­ries each with Form 483 let­ters pub­lished on Dec. 28. This was Dr. Red­dy’s sec­ond let­ter in just two months.

In the lat­est 12-page let­ter for Dr. Red­dy’s site lo­cat­ed at Telan­gana, In­dia, the FDA not­ed in de­tail three ob­ser­va­tions found be­tween Dec. 4 and Dec. 8. The first Form 483 for the gener­ic drug gi­ant fol­lowed an in­spec­tion in Oc­to­ber for a dif­fer­ent unit.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER